United Therapeutic
(UTHR)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Sales | 506,900 | 491,500 | 516,000 | 466,900 | 461,900 |
| Cost of Goods | 52,300 | 58,800 | 37,200 | 29,700 | 25,900 |
| Gross Profit | 454,600 | 432,700 | 478,800 | 437,200 | 436,000 |
| Operating Expenses | 170,500 | 257,900 | 164,700 | 236,100 | 148,900 |
| Operating Income | 284,400 | 175,600 | 314,300 | 201,800 | 288,000 |
| Interest Expense | 13,800 | 12,300 | 9,200 | 6,200 | 4,700 |
| Other Income | 21,300 | 15,500 | 7,400 | -45,000 | 25,400 |
| Pre-tax Income | 291,900 | 178,800 | 312,500 | 150,600 | 308,700 |
| Income Tax | 51,000 | 46,700 | 73,200 | 34,600 | 68,800 |
| Net Income Continuous | 240,900 | 132,100 | 239,300 | 116,000 | 239,900 |
| Net Income | $240,900 | $132,100 | $239,300 | $116,000 | $239,900 |
| EPS Basic Total Ops | 5.20 | 2.85 | 5.26 | 2.56 | 5.31 |
| EPS Basic Continuous Ops | 5.20 | 2.86 | 5.26 | 2.56 | 5.31 |
| EPS Diluted Total Ops | 4.86 | 2.65 | 4.91 | 2.41 | 5.03 |
| EPS Diluted Continuous Ops | 4.86 | 2.64 | 4.91 | 2.41 | 5.03 |
| EBITDA(a) | $297,700 | $188,800 | $327,200 | $214,500 | $300,500 |